Q4 2012

Lanxess Posts Substantially Better Q4 2012 Earnings

Merck KGaA's Profit Up on Cost Cuts, Liquid Crystals

AkzoNobel Announces Q4, FY 2012 Results

BASF Increases Sales and Income from Operations in 2012

Henkel Eyes Further Profit Rise After Record 2012

Vopak Hit as Demand for Oil and Chemical Storage Falls

Canada's Valeant on Hunt for More Deals

Codexis Reports Fourth Quarter and Full Year 2012 Results

Bayer 2013 Outlook Slightly Below Market View

Dendreon Posts Smaller-than-expected Quarterly Loss

Croda's Profit Rises on Strong Consumer Care Sales

Oxea Reports Increased Revenues and Earnings in Q4 2012

Oxea, a global supplier of Oxo Intermediates and Oxo Derivatives, today announced for the fourth quarter of 2012 a strong earnings increase compared with the fourth quarter of 2011.

Borealis Continues to Deliver Strong Results in 2012

AkzoNobel to Speed Up Cost Cutting

Songwon Concludes 2012 with Positive Q4

Reshaped Clariant Increases Q4 Profitability

Total to Raise Exploration Budget

Heavy Flu Season Helps Reckitt Beat Profit Forecasts

Patent Expiries Delay Sanofi's Return to Growth

Kemira Profits Hit by Weak Titanium Dioxide Market

GlaxoSmithKline Promises Growth This Year After 2012 Shortfall

BP's Profits Down as Oil Spill Trial Looms

Rosneft 2012 Net Profit Up 7% While Cash Flow Halved

Merck Worries About Osteoporosis Drug

Exxon, Chevron Earnings Boosted by Refining Margins

Dow Chemical Q4 Profit Misses View

Novo Hikes Forecasts on Hopes for New Blockbuster Drug

Shell Increases Dividend and Chases Growth

Endo Health in Talks with Potential Buyers

AbbVie Forecasts Slower Humira Growth

AstraZeneca's New CEO Warns of Tough Year Ahead

Pfizer Q4 Results Top Forecast

Eli Lilly Q4 Profits Hurt by Generic Competition

Celanese Reports Fourth Quarter 2012 Results

P&G Posts Solid Quarter